CPC A61K 31/444 (2013.01) [A61K 31/53 (2013.01); A61P 35/00 (2018.01)] | 9 Claims |
1. A method of treatment and/or prophylaxis of diffuse large B-cell lymphoma, comprising administering an effective amount of 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{4-[(S-methylsulfonimidoyl)methyl]pyridin-2-yl}pyridin-2-amine of formula I or a physiologically acceptable salt or enantiomer thereof to a patient in need thereof
wherein the diffuse large B-cell lymphoma is a diffuse large B-cell lymphoma which cells have an amplification or translocation of the MYC gene and/or BCL2 gene and/or an overexpression of the BCL2 protein.
|